Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to market its generic Theophylline extended-release tablets used in the treatment of asthma and chronic obstructive pulmonary disease. The approval by the US Food and Drug Administration (USFDA) is for Theophylline extended-release tablets of strengths 300 mg and 450 mg, Zydus Lifesciences said in a regulatory filing.
Rhodes' Generic Theophylline Receives Receives Approval in the U.S.
Leading's Generic Theophylline Receives Approval in the U.S.
Teva's Generic Theophylline Receives Approval in the U.S.
A Missouri-based pharma company, once at the center of a Shkreli-esque generic drug pricing scandal, just lost its chance to challenge the FDA’s complete response letter for its generic drug theophylline, which is used to treat asthma and other respiratory conditions.
Glenmark Pharms Ltd's Generic Theophylline Receives ApprovalIn US
Enforcement Report - Week of April 1, 2020
New Jersey-based generic drugmaker Heritage Pharmaceuticals admitted to fixing prices and will pay more than $7 million in criminal and civil damages, the Department of Justice (DOJ) announced Friday.
Uloric® (Febuxostat): Teijin Limited et al v. MSN Laboratories Private
Pharm's Generic Theophylline Receives Approval In US